Compare HALO & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | WAL |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.7B |
| IPO Year | N/A | 2005 |
| Metric | HALO | WAL |
|---|---|---|
| Price | $62.22 | $87.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 15 |
| Target Price | $73.33 | ★ $99.33 |
| AVG Volume (30 Days) | ★ 2.4M | 839.5K |
| Earning Date | 11-03-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 1.74% |
| EPS Growth | ★ 56.68 | 24.99 |
| EPS | 4.74 | ★ 8.09 |
| Revenue | $1,242,852,000.00 | ★ $3,189,400,000.00 |
| Revenue This Year | $34.83 | $16.21 |
| Revenue Next Year | $24.84 | $9.07 |
| P/E Ratio | $13.14 | ★ $10.83 |
| Revenue Growth | ★ 31.19 | 9.57 |
| 52 Week Low | $46.26 | $57.05 |
| 52 Week High | $79.50 | $94.40 |
| Indicator | HALO | WAL |
|---|---|---|
| Relative Strength Index (RSI) | 34.09 | 67.22 |
| Support Level | $61.23 | $82.55 |
| Resistance Level | $63.26 | $89.23 |
| Average True Range (ATR) | 2.42 | 2.30 |
| MACD | -0.79 | 0.72 |
| Stochastic Oscillator | 7.60 | 86.13 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.